215 related articles for article (PubMed ID: 16475895)
1. Allergy testing: the role of recombinant allergens.
Mothes N; Valenta R; Spitzauer S
Clin Chem Lab Med; 2006; 44(2):125-32. PubMed ID: 16475895
[TBL] [Abstract][Full Text] [Related]
2. From allergen genes to new forms of allergy diagnosis and treatment.
Vrtala S
Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
[TBL] [Abstract][Full Text] [Related]
3. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment.
Hiller R; Laffer S; Harwanegg C; Huber M; Schmidt WM; Twardosz A; Barletta B; Becker WM; Blaser K; Breiteneder H; Chapman M; Crameri R; Duchêne M; Ferreira F; Fiebig H; Hoffmann-Sommergruber K; King TP; Kleber-Janke T; Kurup VP; Lehrer SB; Lidholm J; Müller U; Pini C; Reese G; Scheiner O; Scheynius A; Shen HD; Spitzauer S; Suck R; Swoboda I; Thomas W; Tinghino R; Van Hage-Hamsten M; Virtanen T; Kraft D; Müller MW; Valenta R
FASEB J; 2002 Mar; 16(3):414-6. PubMed ID: 11790727
[TBL] [Abstract][Full Text] [Related]
4. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.
Valenta R; Linhart B; Swoboda I; Niederberger V
Allergy; 2011 Jun; 66(6):775-83. PubMed ID: 21352238
[TBL] [Abstract][Full Text] [Related]
5. Strategies for converting allergens into hypoallergenic vaccine candidates.
Vrtala S; Focke-Tejkl M; Swoboda I; Kraft D; Valenta R
Methods; 2004 Mar; 32(3):313-20. PubMed ID: 14962766
[TBL] [Abstract][Full Text] [Related]
6. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
Valenta R; Vrtala S; Focke-Tejkl M; Bugajska-Schretter ; Ball T; Twardosz A; Spitzauer S; Grönlund H; Kraft D
Biol Chem; 1999; 380(7-8):815-24. PubMed ID: 10494830
[TBL] [Abstract][Full Text] [Related]
7. Component-resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing.
Heiss S; Mahler V; Steiner R; Spitzauer S; Schweiger C; Kraft D; Valenta R
J Invest Dermatol; 1999 Nov; 113(5):830-7. PubMed ID: 10571741
[TBL] [Abstract][Full Text] [Related]
8. Microarrayed allergens for IgE profiling.
Deinhofer K; Sevcik H; Balic N; Harwanegg C; Hiller R; Rumpold H; Mueller MW; Spitzauer S
Methods; 2004 Mar; 32(3):249-54. PubMed ID: 14962759
[TBL] [Abstract][Full Text] [Related]
9. Molecular approaches for new vaccines against allergy.
Niederberger V; Valenta R
Expert Rev Vaccines; 2006 Feb; 5(1):103-10. PubMed ID: 16451112
[TBL] [Abstract][Full Text] [Related]
10. Recombinant allergens for immunotherapy. Where do we stand?
Niederberger V; Valenta R
Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):549-54. PubMed ID: 15640698
[TBL] [Abstract][Full Text] [Related]
11. Microarrayed recombinant allergens for diagnosis of allergy.
Harwanegg C; Laffer S; Hiller R; Mueller MW; Kraft D; Spitzauer S; Valenta R
Clin Exp Allergy; 2003 Jan; 33(1):7-13. PubMed ID: 12534543
[TBL] [Abstract][Full Text] [Related]
12. Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy.
Kazemi-Shirazi L; Niederberger V; Linhart B; Lidholm J; Kraft D; Valenta R
Int Arch Allergy Immunol; 2002 Apr; 127(4):259-68. PubMed ID: 12021544
[TBL] [Abstract][Full Text] [Related]
13. Microarrays: molecular allergology and nanotechnology for personalised medicine (I).
Lucas JM
Allergol Immunopathol (Madr); 2010; 38(3):153-61. PubMed ID: 20398997
[TBL] [Abstract][Full Text] [Related]
14. The future of antigen-specific immunotherapy of allergy.
Valenta R
Nat Rev Immunol; 2002 Jun; 2(6):446-53. PubMed ID: 12093011
[TBL] [Abstract][Full Text] [Related]
15. Allergen-specific immunotherapy with recombinant allergens.
Pauli G; Malling HJ
Curr Top Microbiol Immunol; 2011; 352():43-54. PubMed ID: 21404096
[TBL] [Abstract][Full Text] [Related]
16. Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance.
Campana R; Huang HJ; Freidl R; Linhart B; Vrtala S; Wekerle T; Karaulov A; Valenta R
Semin Immunol; 2017 Apr; 30():67-80. PubMed ID: 28939389
[TBL] [Abstract][Full Text] [Related]
17. Biotechnology-based allergy diagnosis and vaccination.
Bhalla PL; Singh MB
Trends Biotechnol; 2008 Mar; 26(3):153-61. PubMed ID: 18222557
[TBL] [Abstract][Full Text] [Related]
18. Recombinant allergens for pollen immunotherapy.
Wallner M; Pichler U; Ferreira F
Immunotherapy; 2013 Dec; 5(12):1323-38. PubMed ID: 24283843
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.
Tscheppe A; Breiteneder H
Int Arch Allergy Immunol; 2017; 172(4):187-202. PubMed ID: 28467993
[TBL] [Abstract][Full Text] [Related]
20. Allergy--current insights into prevention and diagnostic workup of immediate-type allergy and treatment of allergic rhinoconjunctivitis.
Brehler R; Stöcker B; Grundmann S
J Dtsch Dermatol Ges; 2015 Aug; 13(8):747-62; quiz 763-4. PubMed ID: 26213811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
